The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Preston Heather | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2026 | Chavez Margarita | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2026 | Martell Bridget A | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2026 | Scopa James Paul | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2026 | Nuechterlein Carole | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2026 | Hirth Peter | Director | Grant(A) | 6K | — | $0 |
| Mar 9, 2026 | Blatt Lawrence | President and CEO, Director | Grant(A) | 106K | — | $0 |
| Mar 9, 2026 | Calhoun Lesley Ann | See Remarks | Grant(A) | 37K | — | $0 |
| Mar 9, 2026 | Aneja Nikhil | Principal Accounting Officer | Grant(A) | 9K | — | $0 |
| Mar 9, 2026 | Symons Julian A. | See Remarks | Grant(A) | 23K | — | $0 |
| Jul 16, 2025 | Calhoun Lesley Ann | See Remarks | Grant(A) | 40K | — | $0 |
| Jul 16, 2025 | Symons Julian A. | See Remarks | Grant(A) | 16K | — | $0 |
| Jul 16, 2025 | Blatt Lawrence | President and CEO, Director | Grant(A) | 180K | — | $0 |
| Jun 25, 2025 | Martell Bridget A | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2025 | Chavez Margarita | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2025 | Preston Heather | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2025 | Hirth Peter | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2025 | Scopa James Paul | Director | Grant(A) | 6K | — | $0 |
| Jun 25, 2025 | Nuechterlein Carole | Director | Grant(A) | 6K | — | $0 |
| Feb 28, 2025 | Calhoun Lesley Ann | See Remarks | Grant(A) | 47K | — | $0 |
| Feb 28, 2025 | Symons Julian A. | See Remarks | Grant(A) | 22K | — | $0 |
| Feb 28, 2025 | Blatt Lawrence | President and CEO, Director | Grant(A) | 140K | — | $0 |
| Oct 8, 2024 | Achneck Hardean | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Sep 4, 2024 | Symons Julian A. | See Remarks | Grant(A) | 11K | — | $0 |
| Sep 4, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 34K | — | $0 |
| Sep 4, 2024 | Calhoun Lesley Ann | Insider | Grant(A) | 11K | — | $0 |
| Aug 7, 2024 | Preston Heather | Director | Grant(A) | 120K | — | $0 |
| Aug 7, 2024 | Chavez Margarita | Director | Grant(A) | 120K | — | $0 |
| Jun 27, 2024 | Martell Bridget A | Director | Grant(A) | 60K | — | $0 |
| Jun 27, 2024 | Scopa James Paul | Director | Grant(A) | 60K | — | $0 |
| Jun 27, 2024 | Nuechterlein Carole | Director | Grant(A) | 60K | — | $0 |
| Jun 27, 2024 | Hirth Peter | Director | Grant(A) | 60K | — | $0 |
| Mar 1, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 965K | — | $0 |
| Mar 1, 2024 | Symons Julian A. | See Remarks | Grant(A) | 72K | — | $0 |
| Mar 1, 2024 | Calhoun Lesley Ann | Insider | Grant(A) | 309K | — | $0 |
| Mar 1, 2024 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 72K | — | $0 |
| Feb 28, 2024 | Martell Bridget A | Director | Grant(A) | 9K | — | $0 |
| Feb 28, 2024 | Nuechterlein Carole | Director | Grant(A) | 4K | — | $0 |
| Feb 28, 2024 | Nielsen Jack | Director | Grant(A) | 4K | — | $0 |
| Feb 28, 2024 | Symons Julian A. | See Remarks | Grant(A) | 19K | — | $0 |
| Feb 28, 2024 | Symons Julian A. | See Remarks | Grant(A) | 59K | — | $0 |
| Feb 28, 2024 | Symons Julian A. | See Remarks | Grant(A) | 75K | — | $0 |
| Feb 28, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 132K | — | $0 |
| Feb 28, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 231K | — | $0 |
| Feb 28, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 58K | — | $0 |
| Feb 28, 2024 | Calhoun Lesley Ann | Insider | Grant(A) | 52K | — | $0 |
| Feb 28, 2024 | Calhoun Lesley Ann | Insider | Grant(A) | 75K | — | $0 |
| Feb 28, 2024 | Calhoun Lesley Ann | Insider | Grant(A) | 19K | — | $0 |
| Feb 28, 2024 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Feb 28, 2024 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 16K | — | $0 |
| Feb 28, 2024 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 28, 2024 | Scopa James Paul | Director | Grant(A) | 9K | — | $0 |
| Feb 28, 2024 | Hirth Peter | Director | Grant(A) | 4K | — | $0 |
| Feb 27, 2024 | Martell Bridget A | Director | Disposed to issuer(D) | 30K | — | $0 |
| Feb 27, 2024 | Nuechterlein Carole | Director | Disposed to issuer(D) | 15K | — | $0 |
| Feb 27, 2024 | Nielsen Jack | Director | Disposed to issuer(D) | 15K | — | $0 |
| Feb 27, 2024 | Symons Julian A. | See Remarks | Disposed to issuer(D) | 105K | — | $0 |
| Feb 27, 2024 | Symons Julian A. | See Remarks | Disposed to issuer(D) | 200K | — | $0 |
| Feb 27, 2024 | Symons Julian A. | See Remarks | Disposed to issuer(D) | 26K | — | $0 |
| Feb 27, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Disposed to issuer(D) | 323K | — | $0 |
| Feb 27, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Disposed to issuer(D) | 450K | — | $0 |
| Feb 27, 2024 | Blatt Lawrence | Chief Executive Officer, Director | Disposed to issuer(D) | 81K | — | $0 |
| Feb 27, 2024 | Calhoun Lesley Ann | Insider | Disposed to issuer(D) | 176K | — | $0 |
| Feb 27, 2024 | Calhoun Lesley Ann | Insider | Disposed to issuer(D) | 105K | — | $0 |
| Feb 27, 2024 | Calhoun Lesley Ann | Insider | Disposed to issuer(D) | 26K | — | $0 |
| Feb 27, 2024 | McClure Matthew W. | Chief Medical Officer | Disposed to issuer(D) | 256K | — | $0 |
| Feb 27, 2024 | McClure Matthew W. | Chief Medical Officer | Disposed to issuer(D) | 23K | — | $0 |
| Feb 27, 2024 | McClure Matthew W. | Chief Medical Officer | Disposed to issuer(D) | 92K | — | $0 |
| Feb 27, 2024 | Scopa James Paul | Director | Disposed to issuer(D) | 30K | — | $0 |
| Feb 27, 2024 | Hirth Peter | Director | Disposed to issuer(D) | 15K | — | $0 |
| Oct 25, 2023 | Scopa James Paul | Director | Grant(A) | 183K | $0.76 | $139K |
| Oct 25, 2023 | Scopa James Paul | Director | Grant(A) | 92K | $0.13 | $12K |
| Oct 25, 2023 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 610K | $0.76 | $464K |
| Oct 25, 2023 | Blatt Lawrence | Chief Executive Officer, Director | Grant(A) | 305K | $0.13 | $40K |
| Oct 25, 2023 | Nuechterlein Carole | Director, 10% Owner | Buy(P) | 7.9M | $0.76 | $6.0M |
| Oct 25, 2023 | Nuechterlein Carole | Director, 10% Owner | Buy(P) | 4.0M | $0.13 | $516K |
| Sep 8, 2023 | Blatt Lawrence | Chief Executive Officer | Grant(A) | 150K | — | $0 |
| Sep 8, 2023 | Symons Julian A. | See Remarks | Grant(A) | 48K | — | $0 |
| Sep 8, 2023 | Quan Lucinda Y. | See Remarks | Grant(A) | 48K | — | $0 |
| Sep 8, 2023 | Calhoun Lesley Ann | Insider | Grant(A) | 48K | — | $0 |
| Sep 8, 2023 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 48K | — | $0 |
| Jul 20, 2023 | Nuechterlein Carole | Director | Grant(A) | 20K | — | $0 |
| Jul 20, 2023 | Scopa James Paul | Director | Grant(A) | 20K | — | $0 |
| Jul 20, 2023 | Hirth Peter | Director | Grant(A) | 20K | — | $0 |
| Jul 20, 2023 | Nielsen Jack | Director | Grant(A) | 20K | — | $0 |
| Jul 20, 2023 | Martell Bridget A | Director | Grant(A) | 20K | — | $0 |
| Mar 15, 2023 | Blatt Lawrence | Chief Executive Officer | Grant(A) | 243K | — | $0 |
| Mar 15, 2023 | Beigelman Leonid | President, Director | Grant(A) | 170K | — | $0 |
| Mar 15, 2023 | Quan Lucinda Y. | See Remarks | Grant(A) | 79K | — | $0 |
| Mar 15, 2023 | Calhoun Lesley Ann | Insider | Grant(A) | 79K | — | $0 |
| Mar 15, 2023 | Symons Julian A. | See Remarks | Grant(A) | 79K | — | $0 |
| Mar 15, 2023 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Jul 7, 2022 | McClure Matthew W. | Chief Medical Officer | Grant(A) | 46K | — | $0 |
| Jul 7, 2022 | Quan Lucinda Y. | See Remarks | Grant(A) | 53K | — | $0 |
| Jul 7, 2022 | Calhoun Lesley Ann | Insider | Grant(A) | 53K | — | $0 |
| Jul 7, 2022 | Beigelman Leonid | President, Director | Grant(A) | 113K | — | $0 |
| Jul 7, 2022 | Blatt Lawrence | Chief Executive Officer | Grant(A) | 162K | — | $0 |
| Jul 7, 2022 | Symons Julian A. | See Remarks | Grant(A) | 50K | — | $0 |
| Jun 23, 2022 | Woiwode Thomas | Director | Grant(A) | 15K | — | $0 |
| Jun 23, 2022 | Hirth Peter | Director | Grant(A) | 15K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).